Amino-terminal TACE prodomain attenuates TNFR2 cleavage independently of the cysteine switch

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 288, Issue 6 32-6, 2005, Pages

  Buckley, Caitriona A ^a   Rouhani, Farshid N ^a   Kaler, Maryann ^a   Adamik, Barbara ^a,b   Hawari, Feras I ^a,c   Levine, Stewart J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c KING HUSSEIN CANCER CENTER   (Jordan)

Author keywords

1,10 phenanthroline; 55 kDa type I tumor necrosis factor receptor; 75 kDa type II tumor necrosis factor receptor; A disintegrin and metailoprotease; Tumor necrosis factor converting enzyme

Indexed keywords

1,10 PHENANTHROLINE; CYSTEINE; DISINTEGRIN; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR BINDING PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR 2; ZINC;

AMINO ACID SUBSTITUTION; AMINO ACID SYNTHESIS; AMINO TERMINAL SEQUENCE; ARTICLE; CHEMICAL BOND; ENZYME ACTIVE SITE; ENZYME INHIBITION; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; MONOCYTE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION;

ADAM PROTEINS; CATALYSIS; CATALYTIC DOMAIN; CYSTEINE; HUMANS; METALLOENDOPEPTIDASES; MONOCYTES; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA; ZINC;

EID: 18844409989     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00429.2004     Document Type: Article

References (49)

1. Althoff K, Reddy P, Voltz N, Rose-John S, and Mullberg J. Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins. Eur J Biochem 267: 2624-2631, 2000.
2. Black RA. Tumor necrosis factor-α converting enzyme. Int J Biochem Cell Biol 34: 1-5, 2002.
3. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, and Cerretti DP. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385: 729-733, 1997.
4. Blobel CP. Metalloprotease-disintegrins: links to cell adhesion and cleavage of TNF alpha and Notch. Cell 90: 589-592, 1997.
5. Borroto A, Ruiz-Paz S, De La Torre TV, Borrell-Pages M, Merlos-Suarez A, Pandiella A, Blobel CP, Baselga J, and Arribas J. Impaired trafficking and activation of tumor necrosis factor-α-converting enzyme in cell mutants defective in protein ectodomain shedding. J Biol Chem 278: 25933-25939, 2003.
6. Brou C, Logeat F, Gupta N, Bessia C, LeBail O, Doedens JR, Cumano A, Roux P, Black RA, and Israel A. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell 5: 207-216, 2000.
7. Buxbaum JD, Liu KN, Luo Y, Slack JL, Stocking KL, Peschon JJ, Johnson RS, Castner BJ, Cerretti DP, and Black RA. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem 273: 27765-27767, 1998.
8. Contin C, Pitard V, Itai T, Nagata S, Moreau JF, and Dechanet-Merville J. Membrane-anchored CD40 is processed by the TNF-alpha-converting enzyme: implications for CD40 signaling. J Biol Chem 278: 32801-32809, 2003.
9. Cunnion KM. Tumor necrosis factor receptors encoded by poxviruses. Mol Genet Metab 67: 278-282, 1999.
10. Demaegdt H, Laeremans H, De Backer JP, Mosselmans S, Le MT, Kersemans V, Michotte Y, Vauquelin G, and Vanderheyden PM. Synergistic modulation of cystinyl aminopeptidase by divalent cation chelators. Biochem Pharmacol 68: 893-900, 2004.
11. Doedens JR and Black RA. Stimulation-induced down-regulation of tumor necrosis factor-alpha converting enzyme. J Biol Chem 275: 14598-14607, 2000.
12. Endres K, Anders A, Kojro E, Gilbert S, Fahrenholz F, and Postina R. Tumor necrosis factor-alpha converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulation. Eur J Biochem 270: 2386-2393, 2003.
13. Ermert M, Pantazis C, Duncker HR, Grimminger F, Seeger W, and Ermert L. In situ localization of TNFalpha/beta, TACE and TNF receptors TNF-R1 and TNF-R2 in control and LPS-treated lung tissue. Cytokine 22: 89-100, 2003.
14. Garton KJ, Gough PJ, Blobel CP, Murphy G, Greaves DR, Dempsey PJ, and Raines EW. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem 276: 37993-38001, 2001.
15. Gonzales PE, Solomon A, Miller AB, Leesnitzer MA, Sagi I, and Milla ME. Inhibition of the tumor necrosis factor-alpha-converting enzyme by its pro domain. J Biol Chem 279: 31638-31645, 2004.
16. Greene C, Lowe G, Taggart C, Gallagher P, McElvaney N, and O'Neill S. Tumor necrosis factor-alpha-converting enzyme: its role in community-acquired pneumonia. J Infect Dis 186: 1790-1796, 2002.
17. Hansen HP, Dietrich S, Kisseleva T, Mokros T, Mentlein R, Lange HH, Murphy G, and Lemke H. CD30 shedding from Karpas 299 lymphoma cells is mediated by TNF-alpha-converting enzyme. J Immunol 165: 6703-6709, 2000.
18. Hino T, Nakamura H, Shibata Y, Abe S, Kato S, and Tomoike H. Elevated levels of type II soluble tumor necrosis factor receptors in the bronchoalveolar lavage fluids of patients with sarcoidosis. Lung 175: 187-193, 1997.
19. Kohno T, Brewer MT, Baker SL, Schwartz PE, King MW, Hale KK, Squires CH, Thompson RC, and Vannice JL. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc Natl Acad Sci USA 87: 8331-8335, 1990.
20. Merlos-Suarez A, Ruiz-Paz S, Baselga J, and Arribas J. Meialloprotease-dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme. J Biol Chem 276: 48510-48517, 2001.
21. Milla ME, Leesnitzer MA, Moss ML, Clay WC, Carter HL, Miller AB, Su JL, Lambert MH, Willard DH, Sheeley DM, Kost TA, Burkhart W, Moyer M, Blackburn RK, Pahel GL, Mitchell JL, Hoffman CR, and Becherer JD. Specific sequence elements are required for the expression of functional tumor necrosis factor-alpha-converting enzyme (TACE). J Biol Chem 274: 30563-30570, 1999.
22. Mohan MJ, Seaton T, Mitchell J, Howe A, Blackburn K, Burkhart W, Moyer M, Patel I, Waitt GM, Becherer JD, Moss ML, and Milla ME. The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity. Biochemistry 41: 9462-9469, 2002.
23. Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL, Chen WJ, Clay WC, Didsbury JR, Hassler D, Hoffman CR, Kost TA, Lambert MH, Leesnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su JL, Warner J, Willard D, and Becherer JD. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385: 733-736, 1997.
24. Moss ML, White JM, Lambert MH, and Andrews RC. TACE and other ADAM proteases as targets for drug discovery. Drug Discov Today 6: 417-426, 2001.
25. O'Grady NP, Preas HL, Pugin J, Fiuza C, Tropea M, Reda D, Banks SM, and Suffredini AF. Local inflammatory responses following bronchial endotoxin instillation in humans. Am J Respir Crit Care Med 163: 1591-1598, 2001.
26. Olsen NJ and Stein CM. New drugs for rheumatoid arthritis. N Engl J Med 350: 2167-2179, 2004.
27. Park WY, Goodman RB, Steinberg KP, Ruzinski JT, Radella F II, Park DR, Pugin J, Skerrett SJ, Hudson LD, and Martin TR, Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 164: 1896-1903, 2001.
28. Peiretti F, Canault M, Deprez-Beauclair P, Berthet V, Bonardo B, Juhan-Vague I, and Nalbone G. Intracellular maturation and transport of tumor necrosis factor alpha converting enzyme. Exp Cell Res 285: 278-285, 2003.
29. Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, Russell WE, Castner BJ, Johnson RS, Fitzner JN, Boyce RW, Nelson N, Kozlosky CJ, Wolfson MF, Rauch CT, Cerretti DP, Paxton RJ, March CJ, and Black RA. An essential role for ectodomain shedding in mammalian development. Science 282: 1281-1284, 1998.
30. Petelin M, Naruishi K, Shiomi N, Mineshiba J, Arai H, Nishimura F, Takashiba S, and Murayama Y. Systemic up-regulation of sTNFR2 and IL-6 in Porphyromonas gingivalis pneumonia in mice. Exp Mol Pathol 76: 76-81, 2004.
31. Reddy P, Slack JL, Davis R, Cerretti DP, Kozlosky CJ, Blanton RA, Shows D, Peschon JJ, and Black RA. Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J Biol Chem 275: 14608-14614, 2000.
32. Rio C, Buxbaum JD, Peschon JJ, and Corfas G. Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4. J Biol Chem 275: 10379-10387, 2000.
33. Rovida E, Paccagnini A, Del Rosso M, Peschon J, and Dello Sbarba P. TNF-alpha-converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation. J Immunol 166: 1583-1589, 2001.
34. Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, Wong GHW, Gatanaga T, Granger GA, Lentz R, Raab H, Kohr WJ, and Goeddel DV. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61: 361-370, 1990.
35. Schlondorff J, Becherer JD, and Blobel CP. Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE). Biochem J 347: 131-138, 2000.
36. Schlondorff J and Blobel CP. Metalloprotease-disintegrins: modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding. J Cell Sci 112: 3603-3617, 1999.
37. Schlondorff J, Lum L, and Blobel CP. Biochemical and pharmacological criteria define two shedding activities for TRANCE/OPGL that are distinct from the tumor necrosis factor alpha convertase. J Biol Chem 276: 14665-14674, 2001.
38. Shao MX, Nakanaga T, and Nadel JA. Cigarette smoke induces MUC5AC mucin overproduction via tumor necrosis factor-alpha-converting enzyme in human airway epithelial (NCI-H292) cells. Am J Physiol Lung Cell Mol Physiol 287: L420-L427, 2004.
39. Shao MX, Ueki IF, and Nadel JA. Tumor necrosis factor alpha-converting enzyme mediates MUC5AC mucin expression in cultured human airway epithelial cells. Proc Natl Acad Sci USA 100: 11618-11623, 2003.
40. Smith CA, Davis T, Anderson D, Solam L, Beckman MP, Jerzy R, Dower SK, Cosman D, and Goodwin RG. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248: 1019-1023, 1990.
41. Solomon KA, Pesti N, Wu G, and Newton RC. Cutting edge: a dominant negative form of TNF-alpha converting enzyme inhibits proTNF and TNFRII secretion. J Immunol 163: 4105-4108, 1999.
42. Sunnarborg SW, Hinkle CL, Stevenson M, Russell WE, Raska CS, Peschon JJ, Castner BJ, Gerhart MJ, Paxton RJ, Black RA, and Lee DC. Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J Biol Chem 277: 12838-12845, 2002.
43. Thathiah A, Blobel CP, and Carson DD. Tumor necrosis factor-alpha converting enzyme/ADAM 17 mediates MUC1 shedding. J Biol Chem 278: 3380-3394, 2003.
44. Tillie-Leblond I, Pugin J, Marquette CH, Lamblin C, Saulnier F, Brichet A, Wallaert B, Tonnel AB, and Gosset P. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med 159: 487-494, 1999.
45. Tsao TC, Hong J, Li LF, Hsieh MJ, Liao SK, and Chang KS. Imbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis. Chest 117: 103-109, 2000.
46. Upton C, Macen JL, Schreiber M, and McFadden G. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology 184: 370-382, 1991.
47. Vincent B, Paitel E, Saftig P, Frobert Y, Hartmann D, De Strooper B, Grassi J, Lopez-Perez E, and Checler F. The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem 276: 37743-37746, 2001.
48. Zhang Y, Jiang J, Black RA, Baumann G, and Frank SJ. Tumor necrosis factor-alpha converting enzyme (TACE) is a growth hormone binding protein (GHBP) sheddase: the metalloprotease TACE/ADAM-17 is critical for (PMA-induced) GH receptor proteolysis and GHBP generation. Endocrinology 141: 4342-4348, 2000.
49. Zhao J, Chen H, Peschon JJ, Shi W, Zhang Y, Frank SJ, and Warburton D. Pulmonary hypoplasia in mice lacking tumor necrosis factor-alpha converting enzyme indicates an indispensable role for cell surface protein shedding during embryonic lung branching morphogenesis. Dev Biol 232: 204-218, 2001.